Literature DB >> 20133448

Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling.

Yujun Gan1, Yue Zhang, Douglas J Digirolamo, Jing Jiang, Xiangdong Wang, Xuemei Cao, Kurt R Zinn, David P Carbone, Thomas L Clemens, Stuart J Frank.   

Abstract

GH promotes longitudinal growth and regulates multiple cellular functions in humans and animals. GH signals by binding to GH receptor (GHR) to activate the tyrosine kinase, Janus kinase 2 (JAK2), and downstream pathways including signal transducer and activator of transcription 5 (STAT5), thereby regulating expression of genes including IGF-I. GH exerts effects both directly and via IGF-I, which signals by activating the IGF-I receptor (IGF-IR). IGF-IR is a cell surface receptor that contains intrinsic tyrosine kinase activity within its intracellular domain. In this study, we examined the potential role of IGF-IR in facilitating GH-induced signal transduction, using mouse primary calvarial osteoblasts with Lox-P sites flanking both IGF-IR alleles. These cells respond to both GH and IGF-I and in vitro infection with an adenovirus that drives expression of Cre recombinase (Ad-Cre) dramatically reduces IGF-IR abundance without affecting the abundance of GHR, JAK2, STAT5, or ERK. Notably, infection with Ad-Cre, but not a control adenovirus, markedly inhibited acute GH-induced STAT5 activity (more than doubling the ED(50) and reducing the maximum activity by nearly 50%), while sparing GH-induced ERK activity, and markedly inhibited GH-induced transactivation of a STAT5-dependent luciferase reporter. The effect of Ad-Cre on GH signaling was specific, as platelet-derived growth factor-induced signaling was unaffected by Ad-Cre-mediated reduction of IGF-IR. Ad-Cre-mediated inhibition of GH signaling was reversed by adenoviral reexpression of IGF-IR, but not by infection with an adenovirus that drives expression of a hemagglutination-tagged somatostatin receptor, which drives expression of the unrelated somatostatin receptor, and Ad-Cre infection of nonfloxed osteoblasts did not affect GH signaling. Notably, infection with an adenovirus encoding a C-terminally truncated IGF-IR that lacks the tyrosine kinase domain partially rescued both acute GH-induced STAT5 activity and GH-induced IGF-I gene expression in cells in which endogenous IGF-IR was reduced. These data, in concert with our earlier findings that GH induces a GHR-JAK2-IGF-IR complex, suggest a novel function for IGF-IR. In addition to its role as a key IGF-I signal transducer, this receptor may directly facilitate acute GH signaling. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133448      PMCID: PMC2840807          DOI: 10.1210/me.2009-0357

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  87 in total

1.  Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor.

Authors:  S J Frank; W Yi; Y Zhao; J F Goldsmith; G Gilliland; J Jiang; I Sakai; A S Kraft
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

Review 2.  Molecular mechanism of growth hormone action.

Authors:  C Carter-Su; J Schwartz; L S Smit
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

3.  Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and Stat5 activation.

Authors:  L H Hansen; X Wang; J J Kopchick; P Bouchelouche; J H Nielsen; E D Galsgaard; N Billestrup
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

4.  Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.

Authors:  A Sotiropoulos; S Moutoussamy; F Renaudie; M Clauss; C Kayser; F Gouilleux; P A Kelly; J Finidori
Journal:  Mol Endocrinol       Date:  1996-08

5.  Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites.

Authors:  P L Bergad; H M Shih; H C Towle; S J Schwarzenberg; S A Berry
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

6.  The conserved box 1 motif of cytokine receptors is required for association with JAK kinases.

Authors:  J W Tanner; W Chen; R L Young; G D Longmore; A S Shaw
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

7.  Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro.

Authors:  M Kassem; L Mosekilde; E F Eriksen
Journal:  Growth Regul       Date:  1994-09

8.  Expression of functional growth hormone receptors in cultured human osteoblast-like cells.

Authors:  A Nilsson; D Swolin; S Enerback; C Ohlsson
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

9.  The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.

Authors:  L S Smit; D J Meyer; N Billestrup; G Norstedt; J Schwartz; C Carter-Su
Journal:  Mol Endocrinol       Date:  1996-05

10.  Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1.

Authors:  L S Argetsinger; G W Hsu; M G Myers; N Billestrup; M F White; C Carter-Su
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

View more
  24 in total

Review 1.  Autocrine and Paracrine Actions of IGF-I Signaling in Skeletal Development.

Authors:  Yongmei Wang; Daniel D Bikle; Wenhan Chang
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

Review 2.  The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.

Authors:  H Al-Kharobi; R El-Gendy; D A Devine; J Beattie
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

3.  Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).

Authors:  Yue Zhang; Sajina Gc; Sweta B Patel; Ying Liu; Andrew J Paterson; John C Kappes; Jing Jiang; Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2019-05-14       Impact factor: 4.102

4.  Effects of leptin on pedunculopontine nucleus (PPN) neurons.

Authors:  Paige Beck; Francisco J Urbano; D Keith Williams; Edgar Garcia-Rill
Journal:  J Neural Transm (Vienna)       Date:  2012-12-21       Impact factor: 3.575

5.  DMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH.

Authors:  Zhongbo Liu; Oran D Kennedy; Luis Cardoso; Jelena Basta-Pljakic; Nicola C Partridge; Mitchell B Schaffler; Clifford J Rosen; Shoshana Yakar
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

6.  Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells.

Authors:  Fanxin Ma; Zhe Wei; Chunwei Shi; Yan Gan; Jia Lu; Stuart J Frank; James Balducci; Yao Huang
Journal:  Mol Endocrinol       Date:  2011-10-27

7.  Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.

Authors:  Jie Xu; Yue Zhang; Philip A Berry; Jing Jiang; Peter E Lobie; John F Langenheim; Wen Y Chen; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2011-02-10

8.  Skeletal response of male mice to anabolic hormone therapy in the absence of the Igfals gene.

Authors:  Oran D Kennedy; Hui Sun; Yingjie Wu; Hayden-William Courtland; Garry A Williams; Luis Cardoso; Jelena Basta-Pljakic; Mitchell B Schaffler; Shoshana Yakar
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

9.  Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.

Authors:  Yujun Gan; Ashiya Buckels; Ying Liu; Yue Zhang; Andrew J Paterson; Jing Jiang; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2014-09-11

10.  IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity.

Authors:  Yujun Gan; Yue Zhang; Ashiya Buckels; Andrew J Paterson; Jing Jiang; Thomas L Clemens; Zhong-Yin Zhang; Keyong Du; Yingzi Chang; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.